Skip to main content
Top
Literature
1.
go back to reference Nakasuji T, Kawai K, Ishikawa T, Teraoka K, Takeuchi S, Miyagawa T, et al. Random-start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer. Reprod Med Biol. 2019;18(2):167–72.CrossRef Nakasuji T, Kawai K, Ishikawa T, Teraoka K, Takeuchi S, Miyagawa T, et al. Random-start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer. Reprod Med Biol. 2019;18(2):167–72.CrossRef
2.
go back to reference Qin N, et al. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril. 2016;106(2):334–341.e1.CrossRef Qin N, et al. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril. 2016;106(2):334–341.e1.CrossRef
3.
go back to reference Jochum F, Sananès N, Teletin M, Lichtblau I, Rongières C, Pirrello O. Luteal phase stimulation, the future of fertility preservation? Retrospective cohort study of luteal phase versus follicular phase stimulation. J Gynecol Obstet Hum Reprod. 2019;48(2):91–4.CrossRef Jochum F, Sananès N, Teletin M, Lichtblau I, Rongières C, Pirrello O. Luteal phase stimulation, the future of fertility preservation? Retrospective cohort study of luteal phase versus follicular phase stimulation. J Gynecol Obstet Hum Reprod. 2019;48(2):91–4.CrossRef
4.
go back to reference Cavagna F, Pontes A, Cavagna M, Dzik A, Donadio NF, Portela R, et al. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients. Curr Oncol. 2018;25(6):e527–32.CrossRef Cavagna F, Pontes A, Cavagna M, Dzik A, Donadio NF, Portela R, et al. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients. Curr Oncol. 2018;25(6):e527–32.CrossRef
5.
go back to reference Campos APC, Geber GP, Hurtado R, Sampaio M, Geber S. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients. JBRA Assist Reprod. 2018;22(4):352–4.PubMed Campos APC, Geber GP, Hurtado R, Sampaio M, Geber S. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients. JBRA Assist Reprod. 2018;22(4):352–4.PubMed
6.
go back to reference Shim YJ, Seol A, Lee D, Kim SK, Lee JR, Jee BC, et al. The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins. Obstet Gynecol Sci. 2018;61(2):242–6.CrossRef Shim YJ, Seol A, Lee D, Kim SK, Lee JR, Jee BC, et al. The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins. Obstet Gynecol Sci. 2018;61(2):242–6.CrossRef
7.
go back to reference Bygdeman M, et al. The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy. Hum Reprod. 1994;9(Suppl 1):121–5.CrossRef Bygdeman M, et al. The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy. Hum Reprod. 1994;9(Suppl 1):121–5.CrossRef
8.
go back to reference Kuang Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62–70.e3.CrossRef Kuang Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62–70.e3.CrossRef
9.
go back to reference La Marca A, Capuzzo M. Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Reprod BioMed Online. 2019. La Marca A, Capuzzo M. Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Reprod BioMed Online. 2019.
10.
go back to reference McLernon DJ, et al. Predicting the chances of having a baby with or without treatment at different time points in couples with unexplained subfertility. Hum Reprod. 2019;34(6):1126–38.CrossRef McLernon DJ, et al. Predicting the chances of having a baby with or without treatment at different time points in couples with unexplained subfertility. Hum Reprod. 2019;34(6):1126–38.CrossRef
11.
go back to reference ElMokhallalati Y, et al. Treatment-independent live birth after in-vitro fertilisation: a retrospective cohort study of 2,133 women. Hum Reprod. 2019. ElMokhallalati Y, et al. Treatment-independent live birth after in-vitro fertilisation: a retrospective cohort study of 2,133 women. Hum Reprod. 2019.
Metadata
Title
IVF stimulation in pregnancy: lessons to be learned with implications for the luteal phase start IVF cycle
Authors
Naama Al Mamari
Weon-Yong Son
Melissa Pansera
Ahmed Badeghiesh
Michael H. Dahan
Publication date
01-02-2020
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 2/2020
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-019-01680-x

Other articles of this Issue 2/2020

Journal of Assisted Reproduction and Genetics 2/2020 Go to the issue